
Loading, please wait...

Loading, please wait...

Recent research in Egypt highlights how AI autism screening tools could revolutionize early detection in low- and middle-income countries (LMICs). Currently, fragmented screening systems and a shortage of specialists often delay diagnosis for children with autism spectrum disorder (ASD). Consequently, many children miss the critical window for early intervention. This study explored the feasibility and acceptability of artificial intelligence as a bridge to these gaps while maintaining clinical integrity.
Autism underdiagnosis remains a significant challenge in LMICs due to limited specialist access and sociocultural stigma. Furthermore, urban-rural disparities exacerbate these inequities. AI-powered tools offer a scalable solution for community-based deployment, particularly in underserved regions. However, the study emphasizes that AI should function as a supportive tool rather than a replacement for clinicians. Specifically, it can assist non-specialists in conducting preliminary assessments, thereby streamlining the care pathway.
Stakeholder trust is fundamental to the adoption of AI autism screening tools in clinical practice. During focus group discussions, parents and healthcare professionals identified several critical enablers. These include data security, transparent consent processes, and algorithmic clarity. Moreover, participants highlighted the need for digital literacy support to ensure parents can navigate these technologies confidently. Therefore, robust data governance frameworks must accompany technical development to mitigate concerns about privacy and bias.
For AI tools to be effective in diverse contexts like Egypt or India, cultural adaptation is essential. The research suggests that generic models may fail to capture local behavioral nuances. In addition, participants expressed a strong preference for hybrid models where human oversight remains central. This approach ensures that clinical judgment complements algorithmic speed. Ultimately, integrating AI into existing health systems requires a focus on contextually relevant design and equitable access.
No, stakeholders view AI as a supportive tool intended to enhance scalability and assist non-specialists, not to replace the clinical judgment of specialists.
The main concerns involve data privacy, algorithmic transparency, and ensuring that the tools do not perpetuate existing socioeconomic or diagnostic biases.
Cultural adaptation ensures that screening tools are relevant to local behaviors and languages, preventing inaccuracies that might arise from using models trained on different populations.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not a substitute for professional clinical judgment or diagnosis. Refer to the latest local and national guidelines for clinical practice.
References
Yogarajah P et al. Feasibility and Acceptability of AI-Powered Tools for Early Autism Screening in Egypt: Semistructured Focus Group Study. J Med Internet Res. 2026 Apr 07. doi: 10.2196/82564. PMID: 41945920.
Ministry of Health and Family Welfare. Strategy for AI in Healthcare for India (SAHI). PIB. 2026 Mar 05.
National Institutes of Health (NIH). The Digital Divide in Technologies for Autism: Feasibility Considerations for Low- and Middle-Income Countries. PMC. 2025.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study in Egypt highlights the feasibility and stakeholder perceptions of AI tools for early autism screening, emphasizing the need for cultural adaptation...
6 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today